 |
Previous Article | Next Article 
The Journal of Neuroscience, October 1, 2002, 22(19):8476-8486
Interaction with Neuronal Calcium Sensor NCS-1 Mediates
Desensitization of the D2 Dopamine Receptor
Nadine
Kabbani1,
Laszlo
Negyessy3,
Ridwan
Lin2,
Patricia
Goldman-Rakic3, and
Robert
Levenson1
1 Department of Pharmacology and
2 Neuroscience Graduate Program, Penn State College of
Medicine, Hershey, Pennsylvania 17033, and 3 Department of
Neurobiology, Yale University School of Medicine, New Haven,
Connecticut 06510
 |
ABSTRACT |
Dopaminergic transmission within limbic regions of the brain is
highly dependent on the regulation of D2 receptor activity. Here we
show that the neuronal calcium sensor-1 (NCS-1) can mediate desensitization of D2 dopamine receptors. Analysis of D2 receptors expressed in human embryonic kidney 293 cells indicates that
NCS-1 attenuates agonist-induced receptor internalization via a
mechanism that involves a reduction in D2 receptor phosphorylation.
This effect of NCS-1 was accompanied by an increase in D2
receptor-mediated cAMP inhibition after dopamine stimulation. The
ability of NCS-1 to modulate D2 receptor signaling was abolished after
a single amino acid mutation in NCS-1 that has been shown to impair the calcium-binding properties of NCS-1. Coimmunoprecipitation experiments from striatal neurons reveal that NCS-1 is found in association with
both the D2 receptor and G-protein-coupled receptor kinase 2, a
regulator of D2 receptor desensitization. Colocalization of NCS-1 and
D2 receptors was examined in both primate and rodent brain. In
striatum, NCS-1 and D2 receptors were found to colocalize within sites
of synaptic transmission and in close proximity to intracellular
calcium stores. NCS-1-D2 receptor interaction may serve to couple
dopamine and calcium signaling pathways, thereby providing a critical
component in the regulation of dopaminergic signaling in normal and
diseased brain.
Key words:
dopamine receptor; neuronal calcium sensor-1; GRK; GPCR
desensitization; frequenin; calcium signaling; yeast two-hybrid
 |
INTRODUCTION |
Dopaminergic neurotransmission is
mediated via the distinct signaling properties of D1-like (D1 and D5)
and D2-like (D2, D3, and D4) dopamine receptor subfamilies (Civelli et
al., 1993 ; Missale et al., 1998 ). A number of psychiatric disorders
including Tourette's syndrome and schizophrenia are associated with
imbalances in dopaminergic transmission, possibly caused by alterations
in dopamine receptor signaling (Sealfon and Olanow, 2000 ). This idea is
underscored by the fact that the majority of antipsychotic and
neuroleptic drugs act as antagonists of D2-like receptors (Seeman,
1992 ). However, studies have failed to demonstrate that alterations in dopamine receptors themselves represent the underlying cause of schizophrenia (Henn, 1986 ). Therefore, it is possible that a
dysregulation in dopaminergic signaling may be brought about through
alterations in proteins that serve to regulate signaling through
dopamine and other receptors.
Dopamine receptors belong to the superfamily of G-protein-coupled
receptors (GPCRs) (Civelli et al., 1993 ). The processes of receptor
desensitization and resensitization modulate signaling through GPCRs.
Receptor desensitization, characterized by a decline in receptor
responsiveness to agonist, represents a critical adaptation mechanism
that protects against receptor overstimulation (Lohse, 1993 ; Krupnick
and Benovic, 1998 ). However, receptor desensitization has been shown to
limit the therapeutic usefulness of drugs that act as receptor agonists
and may contribute to features of addiction (Nestler, 1995 ; Self,
1998 ). The desensitization of activated GPCRs is mediated by the
phosphorylation of serine and threonine residues within the
intracellular domains of receptors (Ferguson, 2001 ). Receptor
phosphorylation serves to uncouple receptors from G-protein activation
and promote arrestin binding and internalization (Krupnick and Benovic,
1998 ). Both second messenger-dependent kinases [e.g., protein kinase A
(PKA) and protein kinase C (PKC)] and G-protein-coupled
receptor kinases (GRKs) have been shown to contribute to the
desensitization of activated dopamine receptors (Mason et al., 2002 ).
Although originally thought to mediate agonist-dependent (homologous)
and agonist-independent (heterologous) forms of receptor desensitization, both GRKs and second messenger kinases are now believed to contribute to both forms of receptor desensitization in a
more complex manner (Ferguson, 2001 ). For example, the dopamine-induced desensitization of the D1 receptor appears to be regulated via both
PKA- and GRK-mediated pathways (Jiang and Sibley, 1999 ), whereas the
internalization of activated D2 receptors is enhanced by coexpression
of both GRK2 and GRK5 (Ito et al., 1999 ; Iwata et al., 1999 ).
Therefore, it is likely that the mechanism underlying receptor
desensitization, including the desensitization of subtypes of dopamine
receptors, is modulated by the activity of proteins that can interact
with both the receptor and its kinase.
To identify proteins involved in mediating D2 receptor signaling, we
used the C terminus of the D2 receptor as bait to screen a human brain
cDNA library. One clone isolated from this screen corresponds to
neuronal calcium sensor-1 (NCS-1). NCS-1 is the mammalian ortholog of
frequenin, a calcium-binding protein implicated in mediating several
aspects of neurotransmission, including ion channel regulation (Weiss
et al., 2000 ; Tsujimoto et al., 2002 ) and neurotransmitter release
(McFerran et al., 1999 ; Pan et al., 2002 ; Scalettar et al.,
2002 ). Our studies suggest an additional role for NCS-1 in
modulating GRK-mediated desensitization of activated D2 dopamine
receptors. Regulation of D2 receptor desensitization by NCS-1 may have
significant implications for understanding dopaminergic signaling in
normal brain and in neuropathologies characterized by a dysregulation
in dopaminergic neurotransmission.
 |
MATERIALS AND METHODS |
DNA constructs and protein interaction assays. All
constructs were generated by subcloning PCR amplification products into appropriate vectors, and each construct was verified by automated DNA
sequencing. cDNA fragments encoding the C terminus of the D1 (residues
365-446), D2 (residues 428-443), D3 (residues 385-400), D4 (residues
370-387), and D5 (residues 360-477) receptors were ligated into the
yeast GAL4 DNA-binding domain expression vector pAS2-1 (Clontech, Palo
Alto, CA). For the D2 receptor screen, the D2-pAS2-1 bait plasmid and
the human brain cDNA library in the GAL4 activation domain vector pACT2
(Clontech) were simultaneously cotransformed into the yeast strain
MaV103 as previously described (Lin et al., 2001 ). Positive clones were
identified by growth on
Leu /Trp /His /Ura
selection plates. Protein interaction was assayed for by
-galactosidase activity via the nitrocellulose filter lift method
(Lin et al., 2001 ).
To identify the sites of interaction between D2 or D3 receptors and
NCS-1, truncated or full-length receptor constructs (in pAS2-1) were
assayed for interaction against truncated or full-length NCS-1
constructs (in pACT2) using the yeast two-hybrid method. Bait and prey
plasmids were simultaneously transformed into the yeast strain MaV103
and interactions were assayed as described above.
For expression studies, full-length NCS-1 cDNA was subcloned into the
mammalian expression vectors pEGFP-N [C-terminal enhanced green
fluorescent protein (EGFP) tag; Clontech] or pCB6 (Brewer and Roth,
1991 ). The calcium-defective NCS-1 mutant E120Q was generated by PCR
mutagenesis as previously described (Weiss et al., 2000 ) and subcloned
into the mammalian expression vector pEGFP-N. FLAG-tagged D3
receptor cDNA was generated as previously described (Karpa et al.,
2000 ).
Cell culture and transfection. Human embryonic kidney
(HEK) 293 cells were maintained in DMEM supplemented with
10% fetal bovine serum. HEK 293 cells stably expressing FLAG-tagged
D2L receptors (293-D2 cells) were provided by Dr. Mark von Zastrow (University of California, San Francisco). 293-D2 cells were maintained in DMEM supplemented with 10% fetal bovine serum and 300 µg/ml geneticin/G418 (Invitrogen, Grand Island, NY). Cells were
transfected using the Lipofectamine 2000 transfection reagent
(Invitrogen, Carlsbad, CA) under conditions described by the
manufacturer. Striatal cell cultures were prepared from embryonic day
18 (E18) rat embryos as previously described (Lin et al., 2001 ).
Striatal cultures were maintained in Neurobasal media supplemented with 2% B-27 (Invitrogen), then treated with 10 µM
5-fluoro-5'-deoxyuridine (Sigma, St. Louis, MO) to eliminate glial
proliferation. Experiments were performed on striatal cells maintained
in culture for 2 weeks.
Glutathione S-transferase pull-down and
coimmunoprecipitation. Fusion protein glutathione S-transferase
(GST)-NCS-1 (amino acids 1-190) was constructed in the
expression vector pGEX-4T-1 (Amersham Biosciences, Piscataway, NJ).
GST-NCS-1 fusion protein was induced in Escherichia
coli strain BL21 (DE3) then purified with
glutathione-sepharose (Amersham) according to manufacturer's instructions. GST-pull-down assays were performed as previously described (Lin et al., 2001 ). Eluted proteins were separated by SDS-PAGE and transferred to a nitrocellulose filter. The filter was
probed with M2 anti-FLAG (1:1000 dilution of the monoclonal antibody;
Sigma), anti-D2 receptor (1:500 dilution of the polyclonal antibody;
Santa Cruz Biotechnology, Santa Cruz, CA), and anti-GRK2 (1:1000 of the
polyclonal antibody, Santa Cruz Biotechnology) antibodies.
Immunoprecipitations were performed from crude membranes or total cell
lysates as previously described by Karpa et al. (2000) . FLAG-tagged D2
and D3 receptors were immunoprecipitated using the M2 anti-FLAG
monoclonal antibody. Native D2 receptors were immunoprecipitated with a
polyclonal anti-D2 receptor antibody (Calbiochem, San Diego, CA),
whereas NCS-1 was immunoprecipitated using a polyclonal anti-frequenin
antibody (Rockland Immunochemicals, Gilbertsville, PA). Western
analysis of immunoprecipitated complexes was performed by using
polyclonal anti-frequenin antibody (Rockland Immunochemicals),
polyclonal anti-GRK2 antibody (Santa Cruz Biotechnology), or polyclonal
anti-D2 receptor antibody (Santa Cruz Biotechnology). To block protein
kinase A activity, HEK 293 cells were treated with 10 µM
of the PKA inhibitor H-89
(2-(p-bromocinnamylamino)ethyl-5-Isoquinolinesufonamide; Sigma) for 30 min.
Immunofluorescence. HEK 293 cells were transiently
transfected with plasmids encoding either FLAG-tagged D2 or FLAG-tagged D3 receptors. Detection of dopamine receptors was done by
immunostaining with anti-FLAG M2 monoclonal (1:1000 dilution of the
monoclonal antibody; Sigma). Immunofluorescence was visualized by
confocal laser microscopy using a Zeiss LSM 210 confocal microscope.
For immunostaining of striatal cultures, cells were fixed and
permeabilized as previously described (Lin et al., 2001 ). Double and
triple labeling was performed by overnight incubation with combinations of the following antibodies: NCS-1 (1:600 dilution of a chicken polyclonal anti-frequenin antibody; Rockland Immunochemicals), D2
receptor (1:2000 dilution of a rabbit polyclonal antibody; Calbiochem,
San Diego, CA, or 1:1000 dilution of a goat polyclonal antibody; Santa
Cruz Biotechnology), GRK2 (1:400 dilution of a rabbit polyclonal
antibody; Santa Cruz Biotechnology), and microtubule-associated protein
2 (MAP2) (1:1500 dilution of a rabbit polyclonal antibody; Chemicon, Temecula, CA). Double staining was visualized with a 1:200
dilution of FITC-goat anti-rabbit and Red-X goat anti-chicken secondary
antibodies, whereas triple labeling was visualized with a 1:200
dilution of FITC donkey anti-goat, AMCA donkey anti-chicken, and Red-X
donkey anti-rabbit antibodies (Jackson ImmunoResearch, West Grove,
PA). Fluorescent images were obtained with a Zeiss Axiophot System and
captured with QED imaging software.
Immunoelectron microscopy. Animals used for
immunohistochemistry were housed and treated according to institutional
guidelines. Three adult Wistar rats and two adult rhesus monkeys
(Macaca mulatta) of both sexes were perfused, and brain
tissue was prepared as described (Mrzljak et al., 1998 ).
Sections of striatum were incubated with a cocktail of NCS-1 (1:100
dilution, chicken polyclonal anti-frequenin antibody; Rockland
Immunochemicals) and D2 receptor (1:60 or 1:100 dilution; Levey et al.,
1993 ) antibodies. Primary antibodies were complexed with a mixture of
biotinylated goat anti-chicken (1:200; Vector Laboratories, Burlingame,
CA) and 1 nm gold-coupled goat anti-rabbit (1:50 dilution; Amersham)
secondary antibodies. To visualize immunogold-labeled D2 receptors,
silver enhancement of the gold particles was performed using the
IntenSe intensification kit (Amersham). NCS-1 immunocomplexes were
detected by Vectastain ABC Elite kit (Vector Laboratories) and
visualized by DAB (3'3-diaminobenzodine; Sigma) reactions. Sections
were flat embedded in Durcupan ACM (Fluka, Milwaukee, WI). Ultrathin
sections were poststained with lead citrate and examined on a JEOL 1010 transmission electron microscope.
Cleavable biotin and cAMP assays. Receptor internalization
and cell surface labeling assays were performed using the cleavable biotin method as described by Vickery and von Zastrow (1999) . Briefly,
cells were labeled with 1 mg/ml cleavable sulfo-NHS-S-S-biotin (Pierce,
Rockford, IL) for 30 min at 4°C. Cell surface biotin was then cleaved
by exposing cells to glutathione strip buffer (Vickery and von Zastrow,
1999 ). Biotin-labeled D2 or D3 receptors were immunoprecipitated using
the M2 anti-FLAG monoclonal antibody, resolved by SDS-PAGE, and
transferred to a nitrocellulose filter. Biotinylated receptors were
complexed with horseradish peroxidase using the Vectastain ABC
detection system, then detected by enhanced chemiluminescence with an
ECL Plus kit (Amersham). Quantification of immunoblots was performed by
laser densitometry (Molecular Dynamics, Sunnyvale, CA) and analyzed
using the Quantity One software package (PDI, Inc.). Internalized
receptors are expressed as a percentage of total surface receptors in
membranes that had not been subject to biotin cleavage.
cAMP assays were performed on cell lysates prepared from 293-D2 cells
transiently transfected with either wild-type NCS-1 or the E120Q NCS-1
mutant. In some experiments, cells were subjected to a 12 hr
preincubation with 100 µg/ml pertussis toxin (Calbiochem) before
initiation of the cAMP assay. Measurement of total intracellular cAMP
was performed using a cAMP enzyme immunoassay kit (Amersham) according
to instructions provided by the manufacturer. Statistical analysis was
performed using the Statistica software package.
Whole-cell phosphorylation assays. Whole-cell
phosphorylation assays were performed essentially as described by
Tiberi et al. (1996) . 293-D2 cells were transfected with 10 µg of DNA
1 d before the assay. Cells plated onto 6-well dishes at a density of 1 × 106/well were labeled with
0.2 mCi/ml 32Pi for
3 hr then treated with dopamine. All samples were normalized to total
protein concentration. Phosphorylated receptors were immunoprecipitated
with anti-FLAG M2 monoclonal antibody, then resolved by
SDS-polyacrylamide gel electrophoresis. Gels were dried and exposed to
X-OMAT/Biomax film (Eastman Kodak, Rochester, NY) at -80°C for 5-12
hr. Receptor phosphorylation was quantified using Quantity One software
(Molecular Dynamics).
 |
RESULTS |
Interaction of NCS-1 with dopamine receptors
To identify dopamine receptor interacting proteins, we used the C
terminus of the D2 dopamine receptor (amino acid residues 428-443) to
screen an adult human brain cDNA library. In control experiments the
bait did not cause autologous activation of the reporter gene, as
indicated by lack of -galactosidase activity (data not
shown). Of the 5 × 105
clones screened, one was found to contain the complete open reading frame (ORF) for human NCS-1. NCS-1 is a highly conserved member of the
NCS family of calcium binding proteins, which includes neurocalcin,
hippocalcin, and recoverin. NCS-1 is the mammalian ortholog of the
Drosophila and Xenopus frequenin protein (Pongs et al., 1993 ; Nef et al., 1995 ; Olfasson et al., 1995 ). NCS-1 possesses
three functional and one vestigial EF-hand calcium binding domains and has been shown to mediate several aspects of
neurotransmission (Burgoyne and Weiss, 2001 ).
To examine the specificity of the D2 receptor-NCS-1 interaction, we
used the yeast two-hybrid system to test the interaction of NCS-1 with
additional dopamine receptor family members. Bait constructs encoding
the C-terminal segments of the D1, D2, D3, D4, and D5 receptors were
tested for interaction with NCS-1. Using this assay, we found that
NCS-1 interacts with the D2, D3, and D5 receptors, but not with the D1
or D4 receptor subtypes. These results indicate that NCS-1 can
associate with some but not all members of the D1-like and D2-like
subfamilies in the yeast system.
To confirm interaction between NCS-1 and the D2 receptor, we tested the
ability of D2 receptors to associate with a GST fusion protein
containing the complete NCS-1 ORF. Crude membranes were prepared
from 293-D2 cells and tested for the ability to associate with the
GST-NCS-1 fusion protein. As shown in Figure
1A, a Western blot
containing crude membranes prepared from 293-D2 cells produced a 44 kDa
band immunoreactive with the anti-FLAG M2 monoclonal antibody. This
band corresponds in size to FLAG-tagged D2 receptors detected in
unadsorbed cell lysates. Immunoreactive D2 receptors were not
visualized when membranes were adsorbed onto GST alone or when
membranes were prepared from nontransfected HEK 293 cells.

View larger version (31K):
[in this window]
[in a new window]
|
Figure 1.
Interaction of D2 dopamine receptor with NCS-1.
A, GST-NCS-1 fusion protein was used to pull-down the
D2 receptor from crude membrane preparations of 293-D2 cells.
FLAG-tagged D2 receptors were detected in unabsorbed cell lysates and
pull-down lanes using FLAG-specific M2 antibodies.
Coimmunoprecipitation of NCS-1 with D2 receptors
(B) or D3 receptors (C). An
anti-GFP antibody was used to immunoprecipitate GFP-NCS-1 from crude
membrane preparations of 293-D2 cells transiently transfected with
GFP-NCS-1 (B), or HEK 293 cells transiently
transfected with both GFP-NCS-1 and FLAG-tagged D3 receptors
(C). Blots were probed for either D2 or D3
receptors using anti-FLAG M2 antibodies.
|
|
Interaction between dopamine receptors and NCS-1 was also verified by
coimmunoprecipitation experiments. To demonstrate interaction, we
tested the ability of an anti-green fluorescent protein (GFP) antibody to coimmunoprecipitate NCS-1 and D2 receptors from 293-D2 cells transiently expressing GFP-tagged NCS-1. As shown in Figure 1B, anti-GFP antibody was capable of
coimmunoprecipitating D2 receptors. We also tested the ability of an
anti-GFP antibody to coimmunoprecipitate NCS-1 and D3 receptors from
HEK 293 cells transiently transfected with GFP-tagged NCS-1 plus
FLAG-tagged D3 receptors. As shown in Figure 1C, anti-GFP
antibody was capable of coimmunoprecipitating D3 receptors in these
cells. In these experiments, FLAG-tagged D2 and D3 receptors were not
coimmunoprecipitated from cells transfected with GFP alone or when the
GFP antibody was omitted from the immunoprecipitation reaction. Taken
together, these studies provide strong evidence for an association
between NCS-1 and D2-like dopamine receptors in transfected mammalian cells.
Mapping protein interaction domains
We performed deletion mapping studies to localize sites within
NCS-1 that contribute to NCS-1-D2 receptor interaction. A series of
truncation fragments of NCS-1 were tested for their interaction with
the C terminus of the D2 receptor (amino acids 428-443) in the yeast
two-hybrid assay. As shown in Figure
2A, a minimal fragment containing the N-terminal 71 residues of NCS-1 tested positive in the
-galactosidase assay. A construct encoding residues 72-190 of NCS-1
did not interact with the C terminus of the D2 receptor, confirming
that the N terminus of NCS-1 (amino acids 1-71) is essential for
D2-NCS-1 interaction. Deletion analysis was also used to identify the
site within the C terminus of the D2 receptor that contributes to
the interaction with NCS-1. The 16-amino acid (aa)-long D2 tail (aa
428-443) was subdivided into two fragments corresponding to residues
428-436 and 437-443. As shown in Figure 2B, the
fragment containing residues 428-436 tested positive, whereas the
fragment containing residues 437-443 tested negative in the
-galactosidase assay. An alignment of the C termini of the D2-like
dopamine receptors is shown in Figure 2C. Within the interacting segment, the D2 and D3 receptors are identical, whereas the
D4 receptor differs at three of the nine positions. These nonconserved
residues are likely to be critical for the interaction of D2 and D3
receptors with NCS-1.

View larger version (22K):
[in this window]
[in a new window]
|
Figure 2.
D2 receptor and NCS-1 interaction domains.
A, Schematic representation of constructs encoding
truncations of NCS-1. Constructs were tested for interaction with the
C-terminal tail of the D2 receptor in the two-hybrid assay. Interaction
is indicated by the presence or absence of -galactosidase activity.
Note: all NCS-1 constructs produced approximately the same intensity of
-galactosidase staining. B, Constructs encoding
truncations of the D2 C-terminal tail (aa 428-443) were tested for
interaction with full-length NCS-1 in the two-hybrid assay as above.
C, Amino acid sequence alignment of the C-terminal
domains of the human D2, D3, and D4 receptors. Residues conserved
between the three receptors are boxed, whereas residues
within the putative transmembrane domains are
shaded.
|
|
Interaction of NCS-1 and D2 receptors in cultures of
rat striatum
To further characterize NCS-1-D2 receptor interaction, we
examined the expression of NCS-1 and D2 receptors in cultures of rat
striatum. In double-labeling experiments, coexpression of NCS-1 and the
neuronal marker MAP2 was detected within somatic and dendritic neuronal
regions (Fig. 3A-C). NCS-1
did not colocalize with the astrocytic marker glial fibrillary acidic
protein (GFAP) (data not shown). Double labeling with anti-D2 and
anti-NCS-1 antibodies indicates colocalization of the proteins within
somata and processes of striatal neurons (Fig.
3D-I). These observations suggest that NCS-1
colocalizes with D2 receptors in striatal neurons. Coimmunoprecipitation experiments were performed to test whether NCS-1
and D2 receptors can associate in striatal cultures. D2 receptors were
immunoprecipitated from striatal membrane preparations and
immunocomplexes probed for the presence of NCS-1. Western blot analysis
using anti-NCS-1 antibodies showed the presence of an ~22 kDa band
whose mobility is virtually coincident with that of endogenous NCS-1
expressed in HEK 293 cells (Fig. 3J). This band was
not detected in mock immunoprecipitations in which the anti-D2 receptor
antibody was omitted or in immunoprecipitations using a nonspecific
antibody. These results indicate that NCS-1 and D2 receptors can
associate in striatal neurons.

View larger version (39K):
[in this window]
[in a new window]
|
Figure 3.
Expression of NCS-1 and D2 receptors in primary
striatal neurons from rat brain. Detection of anti-MAP2
(A) and anti-NCS-1 (B) in
double labeling within neurons. Merged image (C)
shows MAP2 and NCS-1 coexpression within neuronal perikarya and
dendritic process of virtually all striatal neurons. Detection of D2
receptors (D) and NCS-1 (E)
in double-labeled cultures. Merged image (F)
shows D2 receptor and NCS-1 coexpression within the cell body and
processes of neurons. High magnification of a representative neuron
(indicated by arrowheads in D-F)
showing expression of D2 receptors (G), NCS-1
(H), and colocalization of the two
proteins (I). Numerous D2-positive,
NCS-1-negative cells display an apparent astrocytic morphology
(D-F). J, Interaction of D2
receptors and NCS-1 in striatal cultures Anti-D2 receptor antibody was
used to immunoprecipitate D2 receptors from crude membrane preparations
of striatal cells. Immunocomplexes were then probed with anti-NCS-1
antibodies. The position of NCS-1 endogenously expressed in HEK 293 cell membranes is shown (HEK 293 lane).
|
|
NCS-1 and D2 receptors colocalize at sites of
synaptic activity
Double immunoelectron microscopic analysis of rat and monkey
striatum was used to gain insight into the subcellular distribution of
NCS-1 and D2 dopamine receptors. NCS-1 immunoreactivity was localized
in dendrites, spines, and occasionally in axonal boutons in the
neuropil of the rat and monkey striatum. In double-labeling experiments, dendrites and spines were the most frequently observed structures exhibiting both NCS-1 and D2 receptor immunoreactivity (Fig.
4a-g). In monkey striatum, D2
and NCS-1 immunoreactivity was found in very close proximity, and
sometimes overlapped, within dendrites (Fig. 4a-c). A
similar overlapping expression of NCS-1 and D2 receptors was also
detected within the spines of both monkey (Fig. 4d,e) and
rat (Fig. 4f,g) striatum. Spines coexpressing NCS-1 and D2
receptors usually formed asymmetric synaptic contacts with axon
terminals containing round synaptic vesicles (Fig. 4d-g). Within double-labeled structures, immunometal particles representing D2
receptor immunoreactivity were often associated with the cytoplasmic surface of the plasma membrane and were found peri- and/or
extrasynaptically (Fig. 4a-g). Morphological
characterization of the double labeling indicates that D2-NCS-1
complexes are situated in close proximity to intracellular calcium
stores. This is the case in spines where double labeling is often
associated with the spine apparatus (Fig. 4f,g) and in
dendrites where immunolabeling associated with the plasma membrane was
often found in close proximity to mitochondria (Fig. 4a-c).
Given that the method used does not allow preservation of the fine
membranous structures of the endoplasmic reticulum, it is highly likely
that the immunolabeling pattern observed in dendrites represents sites
where intracellular calcium stores approach the neuronal plasma
membrane (Berridge, 1998 ). The close spatial proximity of D2 receptor
and NCS-1 immunoreactivity provides compelling evidence for an
interaction between these two proteins within neurons.

View larger version (116K):
[in this window]
[in a new window]
|
Figure 4.
NCS-1 and D2 receptors colocalize within dendritic
shafts and spines. Representative images of immunolabeling of NCS-1
(DAB reaction product) and D2 (immunometal particles) receptors within
dendritic shafts (a-c) and spines (d-g)
of neurons within monkey (a-e) and rat
(f, g) striatum. Silver grains (representing D2
receptors) were detected extrasynaptically (a-d, f, g)
and perisynaptically (e). Within dendritic
spines, the spine apparatus appears to be immunoreactive for NCS-1
(d-g). D2 receptor immunoreactivity is associated with
the membrane of the NCS-1-immunoreactive spine apparatus
(f, g). Note the close spatial contiguity of DAB
deposits (arrows) and silver particles in the dendrite
as well as within spines (b, d, g). An immunonegative
spine is present in the top right corner of
a-c. Arrowheads point to the
postsynaptic density of asymmetric synaptic contacts (d,
e). Scale bar, 200 nm.
|
|
NCS-1-D2 receptor interaction attenuates ligand-induced D2
receptor internalization
To determine the functional significance of NCS-1-D2 receptor
interaction, we examined the effect of overexpressing NCS-1 on D2
receptor signaling. HEK 293 cells were found to endogenously express
NCS-1. A 10-fold increase in NCS-1 expression was observed after
transient transfection of HEK 293 cells with an EGFP-tagged NCS-1
construct (data not shown). Members of the NCS family are predicted to
play a role in regulating desensitization of GPCRs (Burgoyne and Weiss,
2001 ). We used a cleavable biotin assay to analyze the effect of
NCS-1 on D2 receptor internalization. In 293-D2 cells, D2 receptors
exhibit agonist-independent-constitutive internalization. Consistent
with previous reports (Vickery and von Zastrow, 1999 ), we found that
dopamine stimulation increases the net internalization of D2 receptors
twofold to threefold (Fig. 5A). The effects of dopamine
on D2 receptor internalization were virtually abolished in the presence
of 1 µM of the selective D2 receptor antagonist
haloperidol (Fig. 5A). In 293-D2 cells, overexpression of
EGFP-NCS-1 did not significantly alter the total number of D2 receptors
present at the plasma membrane in the absence of dopamine stimulation
(Fig. 5B) (Student's two tailed t test;
n = 3; p < .05). Therefore, we
examined the effect of NCS-1 overexpression on D2 receptor
internalization after dopamine treatment. As shown in Figure
5C, expression of EGFP-NCS-1 produced an ~50% decrease in the total number of D2 receptors internalized following dopamine stimulation as compared with nonstimulated control cells. These results
indicate that NCS-1 can modulate ligand-induced internalization without
altering ligand-independent internalization of the D2 receptor.

View larger version (29K):
[in this window]
[in a new window]
|
Figure 5.
NCS-1-D2 interaction attenuates D2 receptor
internalization. 293-D2 cells were transiently transfected with
expression plasmids encoding either EGFP-NCS-1 or EGFP alone. A
cleavable biotinylation assay was used to examine the effect of NCS-1
on D2 receptor internalization. A, Anti-FLAG M2 antibody
was used to immunoprecipitate D2 receptors from lysates of cells
treated with 10 µM dopamine for 20 min, 10 µM dopamine for 40 min, 10 µM dopamine for
20 min in the presence of 1 µM haloperidol, or untreated
controls. B, Anti-FLAG antibody was used to
immunoprecipitate D2 receptors from crude membranes prepared from
biotinylated cells. The ratio of D2 receptor expressed at the cell
surface was normalized to total D2 receptor to obtain the relative
value of plasma membrane (pm) expression.
C, Anti-FLAG M2 antibody was used to immunoprecipitate
D2 receptors from total lysates of cells treated with 10 µM dopamine for 20 min. The asterisks refer to
Student's t tests performed to indicate statistical
significance between groups; p 0.05.
|
|
NCS-1 overexpression attenuates GRK-mediated internalization of D2
and D3 receptors
We also examined the effect of NCS-1 overexpression on
GRK-mediated internalization of activated D2 and D3 dopamine receptors. In these experiments, FLAG-tagged D2 or D3 receptors were transiently transfected into HEK 293 cells, and receptor internalization was monitored via confocal microscopy and receptor biotinylation assays. In
HEK 293 cells, D2 and D3 receptors were found predominantly at the
plasma membrane in the absence of dopamine stimulation (Fig.
6A,D). After dopamine
treatment both the D2 and D3 receptor subtypes exhibited a
time-dependent translocation from the plasma membrane to cytosolic
compartments (Fig. 6A-F). Consistent with previous reports (Kim et al., 2001 ), we found that the D3 receptor was
more resistant to homolgous desensitization when compared with the D2
receptor (Fig. 6). Overexpression of GRK2 and GRK3 has previously been
shown to augment ligand-mediated sequestration of D2 and D3 receptors,
respectively (Kim et al., 2001 ). We found that overexpression of GRK2
greatly enhanced the agonist-induced internalization of the D2 receptor
(Fig. 6G), whereas overexpression of GRK3 resulted in only a
modest increase in D3 receptor internalization (Fig.
6H). As shown in Figure 6, NCS-1 was found to
attenuate the number of D2 (G) and D3
(H) receptors internalized in the presence of GRK
overexpression. It is noteworthy that NCS-1 appeared to have a more
pronounced effect on D2 versus D3 receptor internalization, although
the significance of this effect is not yet clear.

View larger version (28K):
[in this window]
[in a new window]
|
Figure 6.
Effect of NCS-1 on D2-D3 receptor
internalization. Confocal images of HEK 293 cells transiently
transfected with FLAG-tagged D2 (A-C) or
FLAG-tagged D3 (D-F) receptors. Representative
images of cells stained with anti-FLAG M2 antibody. A,
D, No dopamine; 10 µM dopamine treatment for 25 (B, E); or 60 min (C, F). A
cleavable biotinylation assay was used to examine the effect of NCS-1
on D2 receptor internalization in the presence of GRK2 overexpression
(G), and D3 receptor internalization in the
presence of GRK3 overexpression (H).
|
|
NCS-1-D2 receptor interaction attenuates receptor phosphorylation
and enhances D2 receptor signaling
To determine the effect of NCS-1 on GRK-mediated phosphorylation
of the D2 receptor, we measured D2 receptor phosphorylation in 293-D2
cells. In these cells, D2 receptor phosphorylation increased by more
than twofold after 10 min of dopamine treatment (Fig. 7B). As shown in Figure
7A, dopamine-induced D2 receptor phosphorylation in 293-D2
cells was enhanced by the overexpression of GRK2, GRK3, and GRK5.
Previous reports have shown GRK2 to be a potent regulator of D2
receptor phosphorylation (Ito et al., 1999 ; Iwata et al., 1999 ; Kim et
al., 2001 ). We therefore examined the effects of GRK2 overexpression on
D2 receptor phosphorylation. Compared with control cells,
overexpression of GRK2 resulted in approximately a twofold increase in
dopamine-mediated D2 receptor phosphorylation (Fig. 7B).
NCS-1 appeared to reduce D2 receptor phosphorylation in the presence of
GRK2 overexpression, but this effect was not found to be statistically
significant. However, in the absence of GRK2 overexpression, NCS-1
alone produced a significant decrease in D2 receptor phosphorylation
compared with controls (Fig. 7B). Taken together, these
findings suggest that NCS-1 attenuates dopamine-induced D2 receptor
phosphorylation.

View larger version (15K):
[in this window]
[in a new window]
|
Figure 7.
NCS-1 overexpression attenuates D2 receptor
phosphorylation and increases D2 receptor signaling. D2 receptor
phosphorylation was assayed by immunoprecipitation with an anti-FLAG M2
after a 10 min stimulation with 10 µM dopamine.
A, 293-D2 cells were transiently transfected with GRK2,
GRK3, or GRK5 cDNA. B, 293-D2 cells were transiently
transfected with GRK2, GRK2 plus EGFP-NCS-1, or EGFP-NCS-1
alone. C, D, 293-D2 cells were transiently
transfected with EGFP-NCS-1, EGFP-E120Q, or EGFP alone. Total
cAMP levels were measured in cells treated for 5 min with 100 µM forskolin followed by a 10 min exposure to 10 µM dopamine. C, Transfected 293-D2 cells
were incubated with 100 µg/ml pertussis toxin for 12 hr before the
assay. Error bars indicate SEM. Statistical analysis was performed
using a one-way ANOVA; n = 9;
*p < 0.05.
|
|
In most mammalian cell lines, activation of D2 receptors leads to a
decrease in intracellular cAMP levels via coupling of these receptors
to inhibitory subsets of G-proteins (Missale et al., 1998 ). We examined
the effect of NCS-1-D2 interaction on D2 receptor-mediated cAMP
signaling in 293-D2 cells overexpressing EGFP-NCS-1. In 293-D2 cells,
pretreatment with the Gi/o inhibitor pertussis
toxin virtually abolished the effect of dopamine on cAMP inhibition
(Fig. 7C). After a 10 min exposure of cells to 10 µM dopamine, we found a significant increase
(28.1%) in dopamine-mediated inhibition of total cellular cAMP in
cells overexpressing NCS-1 compared with nontransfected controls (Fig.
7C). This effect of NCS-1 was also abolished after
pretreatment of cells with pertussis toxin, suggesting that NCS-1
overexpression is associated with enhanced D2 receptor signaling via
Gi/o pathways (Fig. 7C).
We investigated the effects of calcium binding to NCS-1 on D2 receptor
signaling by expressing an NCS-1 mutant (E120Q) in 293-D2 cells. The
E120Q mutation occurs in the third EF calcium-binding hand of NCS-1 and
prevents the protein from undergoing calcium-dependent conformational
changes (Weiss et al., 2000 ). Coimmunoprecipitation experiments
indicate that the E120Q interacts as strongly with D2 receptors as does
wild-type NCS-1 (N. Kabbani, unpublished observations). As shown
in Figure 7D, the effect of dopamine on intracellular cAMP
levels was not significantly different between 293-D2 cells transfected
with E120Q and control cells. These results suggest that a
calcium-dependent conformational change in NCS-1 is likely to be
involved in modulating D2 receptor signaling.
D2 receptors, NCS-1, and GRK2 form a signaling complex
Members of the neuronal calcium sensor family have been reported
to directly interact with GRKs and regulate signaling through GPCRs
(Sallese et al., 2000 ; Burgoyne et al., 2001 ). We examined the ability
of NCS-1 to associate with GRK2 by performing coimmunoprecipitation experiments on crude membranes prepared from 293-D2 cells. NCS-1 was
immunoprecipitated from the cells, and immunocomplexes were probed for
the presence of GRK2. As shown in Figure
8A, an immunoreactive band of ~70 kDa that comigrated with GRK2 was detected with anti-GRK2 antibodies. The ability to coimmunoprecipitate GRK2 (endogenously expressed in HEK 293 cells) with NCS-1 was greatly enhanced by exposure
of cells to the cAMP-elevating agent forskolin (100 µM) (Fig. 8A). Similar
results were obtained when cells were treated with 1 mM dibutyryl cAMP (data not shown). When the same
blot was reprobed with anti-D2 receptor antibodies, an immunoreactive band corresponding to the D2 receptor was detected predominantly in the
forskolin-treated cells (Fig. 8B). Taken together,
these results suggest that D2 receptors, NCS-1, and GRK2 form a complex within HEK 293 cells, and that the interaction between these proteins may be mediated via activation of cAMP signaling pathways.

View larger version (40K):
[in this window]
[in a new window]
|
Figure 8.
Interaction of NCS-1 with D2 receptors and GRK2.
A, Anti-NCS-1 antibody was used to immunoprecipitate
endogenous NCS-1 from crude membrane fractions of 293-D2 cells.
Immunocomplexes were probed using anti-GRK2 antibodies.
B, The blot in A was stripped and
reprobed with anti-D2 receptor antibodies. C, Anti-NCS-1
antibody was used to immunoprecipitate endogenous NCS-1 from crude
membrane fractions of 293-D2 cells that were treated with forskolin,
pretreated with H-89, or exposed to H-89 alone. The blot was probed
with anti-GRK2 antibodies. D, GST-NCS-1 fusion protein
was used to pull-down endogenous GRK2 from lysates prepared from 293-D2
cells. Pull-downs were performed in the presence of either 1 mM Ca2+ or 10 mM EDTA. The
blot was probed using an anti-GRK2 antibody. E, The blot
in D was stripped and reprobed using anti-D2 receptor
antibodies. F, GST-NCS-1 fusion protein was used to
pull-down endogenous GRK2 from HEK 293 cells lysate. Pull-downs were
performed in the presence of 100 nM, 1 µM, 10 µM calcium, or in the presence of 10 mM EDTA.
The blot was probed using anti-GRK2 antibodies.
|
|
It is well documented that stimulation of cAMP signaling pathways is
associated with enhanced PKA activity (Pawson and Scott, 1997 ). We
therefore examined the effect of PKA activation on NCS-1-GRK2 interaction in 293-D2 cells pretreated with the PKA specific-inhibiting agent H-89. As shown in Figure 8C, exposure of 293-D2 cells
to 10 µM H-89 before forskolin treatment
markedly reduced NCS-1-GRK2 interaction. These results suggest that
the effect of forskolin on NCS-1-GRK2 interaction is mediated by
activation of PKA.
Association between NCS-1-D2 receptor and NCS-1-GRK2 was also
examined under differing calcium conditions. Total cell lysate prepared
from 293-D2 cells was tested for the ability to associate with
GST-NCS-1 fusion protein in the presence or absence of calcium. As
shown in Figure 8D, an immunoreactive band
corresponding to endogenous GRK2 was detected when calcium was present
in the pull-down. When the same blot was stripped and reprobed with
anti-D2 receptor antibodies, a 44 kDa band immunoreactive
with the anti-D2 receptor antibody was detected either when calcium was
present or chelated in the pull-down assay (Fig. 8E).
These results indicate that association between NCS-1 and the D2
receptor is calcium-independent, whereas, association between NCS-1 and
GRK2 is calcium-dependent.
Interaction between NCS-1 and GRK2 was also tested in the
absence of D2 receptor expression. In these experiments, GST-NCS-1 fusion proteins were tested for their ability to associate with GRK2
(endogenously expressed in HEK 293 cells) at various calcium concentrations. As shown in Figure 8F, an
immunoreactive band corresponding to native GRK2 was detected at
calcium concentrations in the pull-down reaction ranging from 100 nM-10 µM. Consistent with
earlier findings, GRK2 failed to associate with NCS-1 in the presence
of the calcium chelator EDTA. These results indicate that NCS-1-GRK2
interaction can occur in the absence of the D2 receptor, and that
association between these two proteins may ensue over a broad range
of intracellular calcium concentrations.
We used triple label immunofluorescence to determine whether NCS-1, D2
receptors, and GRK2 colocalize within neurons. In striatal cultures,
many neurons coexpress all three proteins (Fig.
9A-C). Overlapping staining
of NCS-1, D2 receptors, and GRK2 was detected predominantly in cell
bodies and dendritic processes (Fig. 9D). NCS-1 was
immunoprecipitated from lysates of primary striatal neurons and
immunocomplexes probed for the presence of GRK2. As demonstrated in
Figure 9E, an immunoreactive band corresponding to GRK2 was
detected in the NCS-1 immunoprecipitate, whereas no band was detected
when lysates were immunoprecipitated with an irrelevant antibody.
Interaction between these proteins is therefore likely to play an
important role in modulating signaling through the D2 dopamine
receptor.

View larger version (74K):
[in this window]
[in a new window]
|
Figure 9.
Coexpression of D2 receptors, NCS-1, and GRK2 in
primary striatal cultures. Epifluorescent detection of NCS-1
(A), D2 receptor (B), and
GRK2 (C) triple labeling within striatal neurons.
The merged image (D) shows coexpression of the
three proteins within striatal neurons. E, Interaction
of NCS-1 and GRK2 in striatal cultures. Anti-NCS-1 antibody was used to
immunoprecipitate endogenous NCS-1 from lysates of primary striatal
cultures. Immunocomplexes were probed with anti-GRK2 antibody. GRK2 was
detected in lysates from striatal cell cultures as well as HEK 293 cells. GRK2 immunoreactivity was not detected when striatal lysates
were immunoprecipitated with a nonspecific ( ) antibody.
|
|
 |
DISCUSSION |
We have demonstrated that D2 dopamine receptors can functionally
interact with NCS-1, a member of the neuronal calcium sensor family of
EF hand calcium-binding proteins (Burgoyne and Weiss, 2001 ). NCS-1 is
highly conserved throughout evolution, and orthologs have been
identified in yeast, Drosophila, Caenorhabditis
elegans, as well as rodents and humans (Pongs et al., 1993 ;
Hendricks et al., 1999 ; Paterlini et al., 2000 ; Bourne et al., 2001 ).
In invertebrate species, the NCS-1 ortholog frequenin has been
implicated in mediating various aspects of neurotransmission, including
K+ channel activation (Poulain et al.,
1994 ; Nakamura et al., 2001 ), Ca2+
channel inhibition and neurotransmitter release (Rivosecchi et al.,
1994 ; Angaut-Petit et al., 1998 ; Wang et al., 2001 ). Furthermore, vertebrate NCS-1 has also been shown to regulate similar aspects of
neurotransmission, as well as inhibit GRK1-mediated phosphorylation of
rhodopsin (DeCastro et al., 1995 ; Nef et al., 1995 ). The results presented in this study implicate NCS-1 in regulation of
neurotransmission through a direct interaction with dopamine receptors.
Our data indicates that NCS-1 is anatomically positioned to regulate D2 receptor signaling at sites of synaptic activity. Regulation of D2
receptor desensitization by NCS-1 may therefore contribute to features
of dopaminergic transmission.
NCS-1 belongs to the recoverin subfamily of EF hand calcium sensor
proteins (Burgoyne and Weiss, 2001 ). Adaptations in light sensitivity
by rhodopsin are critically dependent on the role of recoverin in
mediating rhodopsin kinase phosphorylation and desensitization of
rhodopsin (Calvert et al., 1995 ). To address the hypothesis that NCS-1
may perform cellular functions similar to recoverin, we examined the
effects of NCS-1 overexpression on D2 receptor desensitization. Our
data indicate that NCS-1 expression causes a decrease in D2 receptor
phosphorylation in response to ligand activation. By decreasing D2
receptor phosphorylation, NCS-1 appears to attenuate D2 receptor
internalization. This process is likely to occur in a calcium-sensitive
manner. This proposed mechanism is supported by the fact that the
calcium-binding NCS-1 mutant (E120Q) cannot functionally substitute for
wild-type NCS-1 in transfected cells. In addition, the finding that
NCS-1 was found in association with D2 dopamine receptors and GRK2 in
transfected cells and primary neurons strongly suggests that NCS-1 is
likely to be involved in modulating GRK2-mediated desensitization of the D2 receptor. Our data also indicates that NCS-1-GRK2 interaction occurs in a calcium-dependent manner and that the E120Q NCS-1 mutant
fails to block D2 receptor desensitization. Together, these results are
consistent with the view that NCS-1-GRK2 interaction plays a key role
in regulating signaling through the D2 receptor. Thus, recoverin and
NCS-1 appear to play similar roles in attenuating desensitization of
rhodopsin and dopamine receptors, respectively.
We found that the level of the NCS-1-GRK2-D2 receptor complex was
significantly increased after treatment of cells with the adenylyl
cyclase activator forskolin, raising the possibility that formation of
the NCS-1-GRK2-D2 receptor complex may also be mediated via PKA
activation. Our data indicate that treatment of HEK 293 cells (stably
expressing the D2 receptor) with the PKA-inhibitor H-89 significantly
attenuated the interaction between NCS-1 and GRK2. This result suggests
that PKA activation is likely to participate in the formation of the
NCS-1-GRK2-D2 receptor complex. This is consistent with the
observation that both PKA- and GRK-mediated phosphorylation events play
a critical role in the desensitization of dopamine receptors (Jiang and
Sibley, 1999 ). In addition, GRK2 itself is subject to PKA regulation, a
process that is critical for the plasma membrane targeting and
activation of GRK2 (Pitcher et al., 1998 ; Cong et al., 2001 ). The
phosphorylation of GRK2 by PKA may therefore represent a mechanism by
which GRK2 can associate with membrane proteins, including NCS-1.
Alternatively, forskolin treatment may promote NCS-1-GRK2-D2 complex
formation via a rise in intracellular calcium levels. Previous studies
have shown that activation of cAMP-signaling pathways is associated with increased calcium release from intracellular stores (Wojcikiewicz and Luo, 1998 ; Zanassi et al., 2001 ). NCS-1-GRK2-D2 complex formation therefore may be promoted by an increase in
[Ca2+i] after forskolin
treatment. In this regard, it is interesting to note that within the
brain NCS-1 and D2 receptors were often found to be associated with the
spine apparatus, a site of intracellular calcium storage (Berridge,
1998 ). The positioning of NCS-1 and D2 receptors in close proximity to
intracellular calcium stores supports the hypothesis that changes in
intracellular calcium may regulate the effects of NCS-1 on D2 receptor signaling.
The fact that NCS-1 can regulate desensitization of D2 dopamine
receptors supports the hypothesis that NCS proteins are likely direct
regulators of GPCR signaling (Iacovelli et al., 1999 ). For example,
recoverin has been shown to inhibit the phosphorylation of rhodopsin by
GRK1 (Calvert et al., 1995 ; Chen et al., 1995 ), whereas visinin-like
proteins VILIP-1 and VILIP-3 have been shown to attenuate GRK2-mediated
phosphorylation of the M2 muscarinic receptor (Kato et al., 1998 ).
Members of the NCS family may thus play a general role in receptor
signaling by interacting with subtypes of GRKs to regulate receptor
desensitization. It is possible that NCS proteins exert calcium
sensitivity on the signaling properties of GPCRs. Indeed, the activity
of many GPCRs, including substance P, angiotensin II, and dopamine
receptors, is coupled to fluctuations in intracellular calcium (Muallem
and Wilkie, 1999 ; Bofill-Cardona et al., 2000 ). The regulation of
GRK-mediated desensitization by NCS proteins may therefore provide a
feedback mechanism for regulating GPCR signaling. In this context, it
is interesting to note that the ubiquitous calcium sensor calmodulin
has also been shown to regulate the activity of GRKs (Chuang et al.,
1996 ; Pronin et al., 1997 ). However, NCS-1 exhibits an ~10-fold
higher affinity for calcium than does calmodulin (Cox et al., 1994 ), thus providing a mechanism whereby NCS-1 can modulate receptor-mediated signaling at lower intracellular calcium concentrations than calmodulin.
In directed yeast two hybrid screens, we also detected interaction
between NCS-1 and D3 (D2-like) and D5 (D1-like) dopamine receptors. It
will clearly be of interest to determine the physiological significance
of NCS-1 interaction with each of the different dopamine receptor
subtypes. Truncation mapping identified a 9-amino acid-long segment
located in the C terminus of the D2 receptor that is responsible for
binding NCS-1. The identical sequence is present in the C terminus of
the D3 receptor, suggesting that this segment also represents the site
of D3-NCS-1 interaction. BLAST analysis failed to identify a
region of sequence homology, either in the C terminus or any other
segment, within the D5 dopamine receptor. Because biochemical
experiments support the validity of the D5 receptor-NCS-1 interaction
(Kabbani, unpublished observations), it seems likely that
alternative sequence motifs may be capable of contributing to the
interaction between NCS-1 and different dopamine receptor subtypes. The
interaction of NCS-1 with the D5 receptor raises another issue of
interest. D1-like and D2-like dopamine receptors are believed to signal
via distinct second messenger pathways (Missale et al., 1998 ). In the
striatum, D1 and D2 receptors have been shown to colocalize within
postsynaptic sites (Aizman et al., 2000 ). Our studies indicate that
within striatum, NCS-1 expression is abundant in dendritic shafts and
spines, raising the possibility that NCS-1 can mediate postsynaptic
functions including cross-talk between D1-like and D2-like
receptor-signaling pathways. The fact that NCS-1-GRK2-D2 receptor
complex formation appears to be promoted by increases in intracellular
cAMP and calcium levels suggests that signaling through the D2 receptor
can be functionally coupled to the activation of
(Gq and Gs/olf) pathways
known to be associated with D1-like receptors (Wang et al., 1995 ; Jin
et al., 2001 ).
Previous studies have shown that NCS-1 functions to regulate
calcium-dependent neurotransmitter release (McFerran et al., 1998 ; Chen
et al., 2001 ; Guild et al., 2001 ) and Ca2+
channel activity (Weiss et al., 2000 ; Tsujimoto et al., 2002 ). Therefore, it is tempting to speculate that NCS-1-D2 receptor interaction may also provide a functional link between D2 receptors and
other synaptic proteins. Because NCS-1 appears to play a pivotal role
in regulating dopamine receptor function, it will be important to
determine if there are alterations in NCS-1 structure and function in
neuropathologies associated with dysregulation in dopaminergic signaling.
 |
FOOTNOTES |
Received Feb. 6, 2002; revised July 22, 2002; accepted July 24, 2002.
This work was supported by National Institute of Mental Health Grant
P50-MH44866. We thank Dr. Allan Levey (Emory University) for D2
dopamine receptor antibody and Dr. J. L. Benovic (Thomas Jefferson
University) for GRK cDNA. We are grateful to Klara Szigeti for
excellent assistance with electron microscopy. We thank Drs. Blaise
Peterson, Clare Bergson, and Bernhard Luscher for helpful comments on
this manuscript.
Correspondence should be addressed to Robert Levenson, Penn
State College of Medicine, Department of Pharmacology, Hershey, PA
17033. E-mail: rlevenson{at}hmc.psu.edu.
 |
REFERENCES |
-
Aizman O,
Brismar H,
Uhlen P,
Zettergren E,
Levey AI,
Forssberg H,
Greengard P,
Aperia A
(2000)
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons.
Nat Neurosci
3:226-230[Web of Science][Medline].
-
Angaut-Petit D,
Toth P,
Rogero O,
Faille L,
Tejedor FJ,
Ferrus A
(1998)
Enhanced neurotransmitter release is associated with reduction of neuronal branching in a Drosophila mutant overexpressing frequenin.
Eur J Neurosci
10:423-434[Web of Science][Medline].
-
Berridge MJ
(1998)
Neuronal calcium signaling.
Neuron
21:13-26[Web of Science][Medline].
-
Bofill-Cardona E,
Kudlacek O,
Yang Q,
Ahorn H,
Freissmuth M,
Nanoff C
(2000)
Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G-protein activation switch.
J Biol Chem
275:32672-32680[Abstract/Free Full Text].
-
Bourne Y,
Dannenberg J,
Pollman V,
Marchot P,
Pongs O
(2001)
Immunocytochemical localization and crystal structure of human frequenin (neuronal calcium sensor 1).
J Biol Chem
276:11949-11955[Abstract/Free Full Text].
-
Brewer CB,
Roth MG
(1991)
A single amino acid change in the cytoplasmic domain alters the polarized delivery of influenza virus hemagglutinin.
J Cell Biol
114:413-421[Abstract/Free Full Text].
-
Burgoyne RD,
Weiss JL
(2001)
The neuronal calcium sensor family of Ca2+ binding proteins.
Biochem J
353:1-12[Web of Science][Medline].
-
Calvert PD,
Klenchin VA,
Bownds MD
(1995)
Rhodopsin kinase inhibition by recoverin.
J Biol Chem
270:24127-24129[Abstract/Free Full Text].
-
Chen CK,
Ingelese J,
Lefkowitz RJ,
Hurley JB
(1995)
Ca2+-dependent interaction of recoverin with rhodopsin kinase.
J Biol Chem
270:18060-18066[Abstract/Free Full Text].
-
Chen XL,
Zhong ZG,
Yokoyama S,
Bark C,
Meister B,
Berggren PO,
Roder J,
Higashida H,
Jeromin A
(2001)
Overexpression of rat neuronal calcium sensor-1 in rodent NG108-15 cells enhances synapse formation and transmission.
J Physiol (Lond)
532:649-659[Abstract/Free Full Text].
-
Chuang TT,
Paolucci L,
De Blasi A
(1996)
Inhibition of G protein-coupled receptor kinase subtypes by Ca2+-calmodulin.
J Biol Chem
271:28691-28696[Abstract/Free Full Text].
-
Civelli O,
Bunzow JR,
Grandy DK
(1993)
Molecular diversity of the dopamine receptors.
Annu Rev Pharmacol Toxicol
32:281-307.
-
Cong M,
Perry SJ,
Lin FT,
Fraser ID,
Hu LA,
Chen W,
Pitcher JA,
Scott JD,
Lefkowitz RJ
(2001)
Regulation of membrane targeting of the G protein coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79.
J Biol Chem
276:15192-15199[Abstract/Free Full Text].
-
Cox JA,
Drussel I,
Comte M,
Nef S,
Nef P,
Lenz SE,
Gundelfinger ED
(1994)
Cation binding and conformational changes in VILIP and NCS-1, two neuron-specific calcium-binding proteins.
J Biol Chem
269:32807-32813[Abstract/Free Full Text].
-
DeCastro E,
Nef S,
Fiumelli H,
Lenz SE,
Kawamura S,
Nef P
(1995)
Regulation of rhodopsin phosphorylation by a family of neuronal calcium sensors.
Biochem Biophys Res Commun
216:133-140[Web of Science][Medline].
-
Ferguson SSG
(2001)
Evolving concepts in G-protein coupled receptor endocytosis: the role of receptor desensitization and signaling.
Pharmacol Rev
53:1-24[Abstract/Free Full Text].
-
Guild SB,
Murray AT,
Wilson ML,
Wiegand UK,
Apps DK,
Jin Y,
Rindler M,
Roder J,
Jeromin A
(2001)
Over-expression of NCS-1 in AtT-20 cells affects ACTH secretion and storage.
Mol Cell Endocrinol
184:51-63[Medline].
-
Hendricks KB,
Wang BQ,
Schnieders EA,
Thorner J
(1999)
Yeast homologue of neuronal frequenin is a regulator of phosphatidylinositol-4-OH kinase.
Nat Cell Biol
1:234-241[Web of Science][Medline].
-
Henn FA
(1986)
Neurotransmitter abnormalities in schizophrenia.
In: Biological perspectives of schizophrenia (Helmcehn H,
Henn FA,
eds), pp 299-310. New York: Wiley.
-
Iacovelli L,
Sallese M,
Mariggio S,
De Blasi A
(1999)
Regulation of G-protein-coupled receptor kinase subtypes by calcium sensor proteins.
FASEB
13:1-8[Abstract/Free Full Text].
-
Ito K,
Haga T,
Lameh J,
Sadee W
(1999)
Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5.
Eur J Biochem
260:112-119[Web of Science][Medline].
-
Iwata K,
Ito K,
Fukuzaki A,
Inaki K,
Haga T
(1999)
Dynamin and Rab5 regulate GRK2-dependent internalization of dopamine D2 receptors.
Eur J Biochem
263:596-602[Web of Science][Medline].
-
Jiang D,
Sibley DR
(1999)
Regulation of D1 dopamine receptors with mutations of protein kinase phosphorylation sites: attenuation of the rate of agonist-induced desensitization.
Mol Pharmacol
56:675-683[Abstract/Free Full Text].
-
Jin LQ,
Wang HY,
Friedman E
(2001)
Stimulated D(1) dopamine receptors couple to multiple G alpha proteins in different brain regions.
J Neurochem
78:981-990[Web of Science][Medline].
-
Karpa K,
Lin R,
Kabbani N,
Levenson R
(2000)
The dopamine D3 receptor interacts with itself and the truncated D3 splice variant D3nf: D3-D3nf interaction causes mislocalization of D3 receptors.
Mol Pharmacol
58:677-683[Abstract/Free Full Text].
-
Kato M,
Watanabe Y,
Lino S,
Takaoka Y,
Kobayashi S,
Haga T,
Hidaka H
(1998)
Cloning and expression of a cDNA encoding a new neurocalcin isoforms (neurocalcin a) from bovine brain.
Biochem J
331:871-876.
-
Kim KM,
Valenzano KJ,
Robinson SR,
Yao WD,
Barak LS,
Caron MG
(2001)
Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and
-arrestins.
J Biol Chem
276:37409-37414[Abstract/Free Full Text]. -
Krupnick JG,
Benovic JL
(1998)
The role of receptor kinases and arrestins in G-protein-coupled receptor regulation.
Annu Rev Pharmacol Toxicol
32:289-319.
-
Levey AI,
Hersch SM,
Rye DB,
Sunahara RK,
Niznik HB,
Kitt CA,
Price DL,
Maggio R,
Brann MR,
Ciliax BJ
(1993)
Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies.
Proc Natl Acad Sci USA
90:8861-8865[Abstract/Free Full Text].
-
Lin R,
Karpa K,
Kabbani N,
Goldman-Rakic P,
Levenson R
(2001)
Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with Filamin A.
Proc Natl Acad Sci USA
98:5258-5263[Abstract/Free Full Text].
-
Lohse MJ
(1993)
Molecular mechanisms of membrane receptor desensitization.
Biochim Biophys Acta
1179:171-188[Medline].
-
Mason JN,
Kozell LB,
Neve KA
(2002)
Regulation of dopamine D1 receptor trafficking by protein kinase A-dependent phosphorylation.
Mol Pharmacol
61:806-816[Abstract/Free Full Text].
-
McFerran BW,
Graham ME,
Burgoyne RD
(1998)
Neuronal calcium sensor 1, the mammalian homologue of frequenin, is expressed in chromaffin and PC12 cells and regulates neurosecretion from dense core granules.
J Biol Chem
273:22768-22772[Abstract/Free Full Text].
-
McFerran BW,
Weiss JL,
Burgoyne RD
(1999)
Neuornal calcium sensor1. Characterization of the myristoylated protein, its cellular effects in permeabilized adrenal chromaffin cells, Ca2+-independent membrane association, and interaction with binding proteins, suggesting a role in rapid Ca2+ signal transduction.
J Biol Chem
274:30258-30265[Abstract/Free Full Text].
-
Missale C,
Nash R,
Robinson SW,
Jaber M,
Caron MG
(1998)
Dopamine receptors: from structure to function.
Pharmacol Rev
78:189-225.
-
Mrzljak L,
Levey AI,
Belcher S,
Goldman-Rakic PS
(1998)
Localization of the m2 muscarinic acetyl-choline receptor protein and mRNA in cortical neurons of the normal and cholinergically deafferented rhesus monkey.
J Comp Neurol
390:112-132[Web of Science][Medline].
-
Muallem S,
Wilkie TM
(1999)
G protein-dependent Ca2+ signaling complexes in polarized cells.
Cell Calcium
26:173-180[Web of Science][Medline].
-
Nakamura TY,
Pountney DJ,
Ozaita A,
Nandi S,
Ueda S,
Rudy B,
Coetzee WA
(2001)
A role for frequenin, a Ca2+-binding protein, as a regulator of Kv4 K+-currents.
Proc Natl Acad Sci USA
98:12808-12813[Abstract/Free Full Text].
-
Nef S,
Fiumelli H,
DeCastro E,
Raes MB,
Nef P
(1995)
Identification of a neuronal calcium sensor (NCS-1) possibly involved in the regulation of receptor phosphorylation.
J Recept Signal Transduct Res
15:365-378[Web of Science][Medline].
-
Nestler EJ
(1995)
Molecular basis of addictive states.
The Neuroscientist
1:212-220.
-
Olfasson P,
Wang T,
Lu B
(1995)
Molecular cloning and functional characterization of the Xenopus Ca2+-binding protein frequenin.
Proc Natl Acad Sci USA
92:8001-8005[Abstract/Free Full Text].
-
Pan CY,
Jeromin A,
Lundstrom K,
Yoo SH,
Roder J,
Fox AP
(2002)
Alterations in exocytosis induced by neuronal calcium sensor-1 in bovine chromaffin cells.
J Neurosci
22:2427-2433[Abstract/Free Full Text].
-
Paterlini M,
Revilla V,
Grant AL,
Wisden W
(2000)
Expression of the neuronal calcium sensor protein family in the rat brain.
Neuroscience
99:205-216[Web of Science][Medline].
-
Pawson T,
Scott JD
(1997)
Signaling through scaffold, anchoring, and adaptor proteins.
Science
278:2075-2080[Abstract/Free Full Text].
-
Pitcher JA,
Freedman NJ,
Lefkowitz R
(1998)
G protein-coupled receptor kinases.
Annu Rev Biochem
67:653-692[Web of Science][Medline].
-
Pongs O,
Lindemeier J,
Zhu XR,
Theil T,
Engelkamp D,
Krah-Jentgens I,
Lambrecht HG,
Koch KW,
Schwemer J,
Rivosecchi R,
Mallart A,
Galceran J,
Canal I,
Barbas JA,
Ferrus A
(1993)
Frequenin-a novel calcium binding protein that modulates synaptic efficacy in the Drosophila nervous system.
Neuron
11:15-28[Web of Science][Medline].
-
Poulain C,
Ferrus A,
Mallart A
(1994)
Modulation of type A K+ current in Drosophila larval muscle by internal Ca2+; effects of the overexpression of frequenin.
Pflügers Arch
427:71-79[Web of Science][Medline].
-
Pronin AN,
Satpaev DK,
Slepak VZ,
Benovic JL
(1997)
Regulation of G protein coupled receptor kinases by calmodulin and localization of the calmodulin binding domain.
J Biol Chem
272:18273-18280[Abstract/Free Full Text].
-
Rivosecchi R,
Pongs O,
Theil T,
Mallart A
(1994)
Implication of frequenin in the facilitation of transmitter release in Drosophila.
J Physiol (Lond)
474:223-232[Abstract/Free Full Text].
-
Sallese M,
Iacovelli L,
Cumashi A,
Capobianco L,
Cuomo L,
De Blasi A
(2000)
Regulation of G protein-coupled receptor kinase subtypes by calcium sensor proteins.
Biochem Biophys Acta
1498:112-121[Medline].
-
Scalettar BA,
Rosa P,
Taverna E,
Francolini M,
Tsuboi T,
Terakawa S,
Koizumi S,
Roder J,
Jeromin A
(2002)
Neuronal calcium sensor-1 binds to regulated secretory organelles and functions in basal and stimulated exocytosis in PC12 cells.
J Cell Sci
115:2399-2412[Abstract/Free Full Text].
-
Sealfon SC,
Olanow CW
(2000)
Dopamine receptors: from structure to behavior.
Trends Neurosci
23:S34-S40[Web of Science][Medline].
-
Seeman P
(1992)
Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.
Neuropsychopharmacology
7:261-284[Web of Science][Medline].
-
Self DW
(1998)
Neural substrates of drug craving and relapse in drug addiction.
Ann Med
30:379-389[Web of Science][Medline].
-
Tiberi M,
Nash SR,
Bertrand L,
Lefkowitz RJ,
Caron MG
(1996)
Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases.
J Biol Chem
271:3771-3778[Abstract/Free Full Text].
-
Tsujimoto T,
Jeromin A,
Saitoh N,
Roder JC,
Takahashi T
(2002)
Neuronal calcium sensor-1 and activity dependent facilitation of P/Q-type calcium currents at presynaptic nerve terminals.
Science
295:2276-2279[Abstract/Free Full Text].
-
Vickery RG,
von Zastrow M
(1999)
Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytotic membranes.
J Cell Biol
144:31-43[Abstract/Free Full Text].
-
Wang CY,
Yang F,
He X,
Chow A,
Du J,
Russell JT,
Lu B
(2001)
Ca2+ binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release.
Neuron
32:99-112[Web of Science][Medline].
-
Wang HY,
Undie AS,
Friedman E
(1995)
Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation.
Mol Pharmacol
48:988-994[Abstract].
-
Weiss JL,
Archer DA,
Burgoyne RD
(2000)
NCS-1/frequenin functions in an autocrine pathway regulating Ca2+ channels in bovine adrenal chromaffin cells.
J Biol Chem
275:40082-40087[Abstract/Free Full Text].
-
Wojcikiewicz RJH,
Luo SG
(1998)
Phosphorylation of inositol 1, 4, 5-triphosphate receptors by cAMP-dependent protein kinase.
J Biol Chem
273:5670-5677[Abstract/Free Full Text].
-
Zanassi P,
Paolillo M,
Feliciello A,
Avvedimento EV,
Gallo V,
Schinnelli S
(2001)
cAMP-dependent protein kinase induces cAMP-response element binding protein phosphorylation via intracellular calcium release/ERK-dependent pathway in striatal neurons.
J Biol Chem
276:11487-11495[Abstract/Free Full Text].
Copyright © 2002 Society for Neuroscience 0270-6474/02/22198476-11$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
N. Kabbani, M. P. Woll, R. Levenson, J. M. Lindstrom, and J.-P. Changeux
Intracellular complexes of the 2 subunit of the nicotinic acetylcholine receptor in brain identified by proteomics
PNAS,
December 18, 2007;
104(51):
20570 - 20575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hui, G.-H. Fei, B. J. Saab, J. Su, J. C. Roder, and Z.-P. Feng
Neuronal calcium sensor-1 modulation of optimal calcium level for neurite outgrowth
Development,
December 15, 2007;
134(24):
4479 - 4489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Iizuka, Y. Sei, D. R. Weinberger, and R. E. Straub
Evidence That the BLOC-1 Protein Dysbindin Modulates Dopamine D2 Receptor Internalization and Signaling But Not D1 Internalization
J. Neurosci.,
November 7, 2007;
27(45):
12390 - 12395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. B. Freimer, S. K. Service, R. A. Ophoff, A. J. Jasinska, K. McKee, A. Villeneuve, A. Belisle, J. N. Bailey, S. E. Breidenthal, M. J. Jorgensen, et al.
A quantitative trait locus for variation in dopamine metabolism mapped in a primate model using reference sequences from related species
PNAS,
October 2, 2007;
104(40):
15811 - 15816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-Y. Cho, D.-I. Cho, J. H. Park, H. Kurose, M. G. Caron, and K.-M. Kim
Roles of Protein Kinase C and Actin-Binding Protein 280 in the Regulation of Intracellular Trafficking of Dopamine D3 Receptor
Mol. Endocrinol.,
September 1, 2007;
21(9):
2242 - 2254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ruiz-Gomez, B. Mellstrom, D. Tornero, E. Morato, M. Savignac, H. Holguin, K. Aurrekoetxea, P. Gonzalez, C. Gonzalez-Garcia, V. Cena, et al.
G Protein-coupled Receptor Kinase 2-mediated Phosphorylation of Downstream Regulatory Element Antagonist Modulator Regulates Membrane Trafficking of Kv4.2 Potassium Channel
J. Biol. Chem.,
January 12, 2007;
282(2):
1205 - 1215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Perez, F. J. White, and X.-T. Hu
Dopamine D2 Receptor Modulation of K+ Channel Activity Regulates Excitability of Nucleus Accumbens Neurons at Different Membrane Potentials
J Neurophysiol,
November 1, 2006;
96(5):
2217 - 2228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brackmann, S. Schuchmann, R. Anand, and K.-H. Braunewell
Neuronal Ca2+ sensor protein VILIP-1 affects cGMP signalling of guanylyl cyclase B by regulating clathrin-dependent receptor recycling in hippocampal neurons
J. Cell Sci.,
June 1, 2005;
118(11):
2495 - 2505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Jeanneteau, J. Diaz, P. Sokoloff, and N. Griffon
Interactions of GIPC with Dopamine D2, D3 but not D4 Receptors Define a Novel Mode of Regulation of G Protein-coupled Receptors
Mol. Biol. Cell,
February 1, 2004;
15(2):
696 - 705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Strahl, B. Grafelmann, J. Dannenberg, J. Thorner, and O. Pongs
Conservation of Regulatory Function in Calcium-binding Proteins: HUMAN FREQUENIN (NEURONAL CALCIUM SENSOR-1) ASSOCIATES PRODUCTIVELY WITH YEAST PHOSPHATIDYLINOSITOL 4-KINASE ISOFORM, Pik1
J. Biol. Chem.,
December 5, 2003;
278(49):
49589 - 49599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. O'Callaghan, B. Hasdemir, M. Leighton, and R. D. Burgoyne
Residues within the myristoylation motif determine intracellular targeting of the neuronal Ca2+ sensor protein KChIP1 to post-ER transport vesicles and traffic of Kv4 K+ channels
J. Cell Sci.,
December 1, 2003;
116(23):
4833 - 4845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bahi, G. Friocourt, A. Carrie, M. E. Graham, J. L. Weiss, P. Chafey, F. Fauchereau, R. D. Burgoyne, and J. Chelly
IL1 receptor accessory protein like, a protein involved in X-linked mental retardation, interacts with Neuronal Calcium Sensor-1 and regulates exocytosis
Hum. Mol. Genet.,
June 15, 2003;
12(12):
1415 - 1425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. O. Koh, A. S. Undie, N. Kabbani, R. Levenson, P. S. Goldman-Rakic, and M. S. Lidow
Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients
PNAS,
January 7, 2003;
100(1):
313 - 317.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|